コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 human African trypanosomiasis (HAT; African sleeping sickness).
2 and reduce the high mortality resulting from sleeping sickness.
3 thway as a drug target against African human sleeping sickness.
4 a brucei is the etiological agent of African sleeping sickness.
5 opment of novel therapeutics against African sleeping sickness.
6 osoma brucei, the causative agent of African sleeping sickness.
7 cei is an extracellular parasite that causes sleeping sickness.
8 ODC is a proven drug target to treat African sleeping sickness.
9 volved with restocking was a risk factor for sleeping sickness.
10 ven drug target for the treatment of African sleeping sickness.
11 m Trypanosoma brucei, the causative agent of sleeping sickness.
12 hould be considered to prevent the spread of sleeping sickness.
13 ally explain the weight loss associated with sleeping sickness.
14 m Trypanosoma brucei, the causative agent of sleeping sickness.
15 t for human African trypanosomiasis (HAT) or sleeping sickness.
16 n disease called African trypanosomiasis, or sleeping sickness.
17 asite that causes the deadly disease African sleeping sickness.
18 seases, including malaria, dengue fever, and sleeping sickness.
19 ucei rhodesiense, the cause of acute African sleeping sickness.
20 n trypanosomiasis (HAT), also called African sleeping sickness.
21 panosoma brucei, the causal agent of African sleeping sickness.
22 fforts to develop new treatments for African sleeping sickness.
23 ed by the tsetse fly and that causes African sleeping sickness.
24 the future therapeutic treatment of African sleeping sickness.
25 an African trypanosomiasis (HAT), or African sleeping sickness.
26 trypanosomiasis (HAT), also known as African sleeping sickness.
27 is a parasitic protozoan that causes African sleeping sickness.
28 osoma brucei, the causative agent of African sleeping sickness.
29 isease and human African trypanosomiasis, or sleeping sickness.
30 panosomal infection and protect from African sleeping sickness.
31 flagellum, is the causative agent of African sleeping sickness.
32 of such an approach for treatment of African sleeping sickness.
33 use the fatal human disease known as African sleeping sickness.
34 eneration of diamidines for the treatment of sleeping sickness.
35 lular protozoan parasite that causes African sleeping sickness.
36 ambiense Human African Trypanosomiasis (HAT, sleeping sickness), a disease that has often been consid
37 oma brucei is the causative agent of African sleeping sickness, a devastating disease endemic to sub-
39 ing target to develop new treatments against sleeping sickness, a fatal disease caused by this protoz
40 t and Southern Africa are foci for Rhodesian sleeping sickness, a fatal zoonotic disease caused by tr
41 animal trypanosomiases, including Rhodesian sleeping sickness, a zoonosis associated with wilderness
42 e Trypanosoma brucei, the causative agent of sleeping sickness across sub-Saharan Africa, depends on
43 rucei causes human African trypanosomiasis ("sleeping sickness") across sub-Saharan Africa and is a m
45 , leishmaniasis, Chagas disease, and African sleeping sickness affect hundreds of millions of people
47 Human African trypanosomiasis, also known as sleeping sickness, affects the CNS at the late stage of
48 here is little hope of a vaccine for African sleeping sickness and a desperate need for modern drug t
49 oma brucei is the causative agent of African sleeping sickness and is known for its unique RNA proces
52 cei, the causative pathogen of human African sleeping sickness and nagana in domestic animals, myo-in
53 ia mexicana, the causative agents of African sleeping sickness and one form of leishmaniasis, respect
54 at includes the causative agents for African sleeping sickness and other devastating tropical and sub
55 osoma brucei, the causative agent of African sleeping sickness, and GlcNAc-PI de-N-acetylase has prev
56 ive, T. b. rhodesiense, which causes African sleeping sickness, and the non-human infective T. b. bru
57 osoma brucei, the causative agent of African sleeping sickness; and Plasmodium spp., the causative ag
58 trends in the development of diagnostics for sleeping sickness are considered and progress towards a
61 soma brucei rhodesiense causes human African sleeping sickness because it has evolved an inhibitor of
62 ovide different levels of protection against sleeping sickness, but this comes with an increased risk
64 en argued that the risk for trypanosomiasis (sleeping sickness), carried by tsetse flies in bushy env
71 evastating tropical diseases such as African sleeping sickness, Chagas' disease and leishmaniasis.
72 mania major, the causative agents of African sleeping sickness, Chagas' disease, and leishmaniasis.
74 anosoma brucei, a causative agent of African Sleeping Sickness, constantly changes its dense variant
76 osoma brucei, the etiologic agent of African Sleeping Sickness, deploys an RNA pol II that contains a
77 osoma brucei, the causative agent of African sleeping sickness, differs from its human host in severa
78 osoma brucei, the causative agent of African sleeping sickness, evades the host immune response by fr
82 anosoma brucei, the causative agent of human sleeping sickness, has an intrinsic circadian clock that
85 Trypanosoma brucei, the causative agent of sleeping sickness (Human African Trypanosomiasis, HAT),
86 orcement of surveillance, for the control of sleeping sickness (human African trypanosomiasis, HAT).
87 Trypanosoma brucei, the causative agent of sleeping sickness in Africa, undergoes antigenic variati
90 e epidemic of Trypanosoma brucei rhodesiense sleeping sickness in eastern Uganda, which began in 1998
91 oma brucei is the causative agent of African sleeping sickness in humans and contributes to the debil
92 Trypanosoma brucei, the causative agent of sleeping sickness in humans and livestock, expresses at
94 cei causes African trypanosomiasis, known as sleeping sickness in humans and nagana in domestic anima
95 the diseases caused by African trypanosomes: sleeping sickness in humans and Nagana in livestock.
96 oma brucei is the causative agent of African sleeping sickness in humans and one of the causes of nag
98 panosomes are protozoan parasites that cause sleeping sickness in humans through a tsetse fly vector.
105 itted trypanosomes (Trypanosoma spp.) cause "sleeping sickness' in man and have a serious impact on l
106 ma brucei rhodesiense (agent of east African sleeping sickness), including a multidrug resistant clon
110 e disease away from the market suggests that sleeping sickness is becoming established in this new fo
112 African trypanosomiasis (HAT), also known as sleeping sickness, is a major cause of mortality and mor
113 Human African trypanosomiasis (HAT), or sleeping sickness, is a major threat to human health thr
114 Human African trypanosomiasis, also known as sleeping sickness, is a neglected disease, and it contin
117 osoma brucei, the protozoan parasite causing sleeping sickness, is transmitted by a tsetse fly vector
118 osoma brucei, the causative agent of African sleeping sickness, is transmitted to its mammalian host
119 , which cause such human diseases as African sleeping sickness, leishmaniasis and Chagas disease.
120 Trypanosomatids, the etiologic agents of sleeping sickness, leishmaniasis, and Chagas' disease, c
121 Trypanosoma brucei, the etiological agent of sleeping sickness, localized its replication origins to
122 he parasitic trypanosomes that cause African sleeping sickness, mating occurs during transmission by
124 orm Trypanosoma brucei, the agent of African sleeping sickness, normally requires mitochondrial gene
126 copeia for human African trypanosomiasis (or sleeping sickness), orally dosed fexinidazole stands poi
127 port on a recent outbreak of T b rhodesiense sleeping sickness outside the established south-east Uga
128 ket was a highly significant risk factor for sleeping sickness (p<0.001) and that there was a signifi
129 evelopmental events in the life-cycle of the sleeping sickness parasite comprise integrated changes i
130 e-3-phosphate dehydrogenase (GAPDH) from the sleeping sickness parasite Trypanosoma brucei is a ratio
136 ction of rare cell types in blood (including sleeping sickness parasites), and has the potential to e
139 oma brucei is the causative agent of African sleeping sickness, putting at risk up to 50 million peop
140 osoma brucei, the causative agent of African sleeping sickness, relies on glycolysis as its sole ener
144 tance against Trypanosoma that cause African sleeping sickness, resulting in positive selection of th
145 ite Trypanosoma brucei, which causes African sleeping sickness, TbISWI down-regulates RNA polymerase
146 osoma brucei (the causative agent of African sleeping sickness) the glycosylphosphatidylinositol (GPI
147 osomes, protozoan parasites that cause human sleeping sickness, the increased levels of IFN-gamma do
149 occurs in the protozoan that causes African sleeping sickness (Trypanosoma brucei), and the protein
151 s typified by the causative agent of African sleeping sickness, Trypanosoma brucei In mitochondria of
152 energy metabolism in the causative agent of sleeping sickness, Trypanosoma brucei, with that of huma
155 de that one mechanism of resistance of human sleeping-sickness trypanosomes to human serum is decreas
156 can trypanosomes, parasites that cause human sleeping sickness, undergo a density-dependent different
157 cei, a eukaryotic human parasite that causes sleeping sickness, uses three elongases instead of type
158 f Trypanosoma brucei rhodesiense (Rhodesian) sleeping sickness, which is a fatal zoonotic disease tha
159 tive agent of Human African Trypanosomiasis (sleeping sickness), yet little is known about which PKs
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。